Skip to main content
. 2014 Jan 6;2014:954508. doi: 10.1155/2014/954508

Figure 4.

Figure 4

Platycodin D had a therapeutic effect on the CIA mice mediated by anti-inflammatory, antioxidative, and immunomodulatory effects. (a) Paw MPO and MDA contents of platycodin D-treated mice were lower compared to CIA control mice. (b) Paw TNF-α and IL-6 levels in platycodin D-treated mice were lower compared with CIA control mice. (c) Splenocyte TNF-α and IL-6 levels in platycodin D-treated mice were lower compared with CIA control mice. Values are expressed as means ± SD (n = 8); a P < 0.01 as compared with intact control by LSD test; b P < 0.01 as compared with CIA control by LSD test; c P < 0.01 and d P < 0.05 as compared with intact control by MW test; e P < 0.01 and f P < 0.05 as compared with CIA control by MW test.